EIT Cellular Titanium vs. PEEK with autograft: 6 things to know

Written by Shayna Korol | May 04, 2018 | Print  |

Emerging Implant Technologies' EIT Cellular Titanium Scaffold provides greater primary stability, less subsidence and similar fusion results to PEEK in combination with autograft, according to the results of the EFFECT trial.

Here are six things to know.

1. EIT is a German medical device manufacturer focused on creating spinal implants with additive manufacturing.

2. The company's implants are made of 3D-printed EIT Cellular Titanium with a porosity of 80 percent.

3. The EFFECT trial is a prospective controlled trial evaluating the radiological results of 50 patients who received a single level standalone EIT Cervical Implant with no addition of biologics and no use of a plate or screw fixation.

4. Results at three months, six months and one year were compared to historical data of a patient cohort with single level standalone PEEK cages with autograft that evaluated the same outcome parameters.

5. All clinical parameters improved significantly at three months follow up for the EIT Cervical Implant cohort, with a slight improvement further over time. The results did not differ from the clinical outcome in the PEEK-autograft cohort.

6. The EIT Cervical Implant had a lower subsidence rate than the PEEK cage.

More articles on surface technology:

Titanium implants to dominate global plasma-sprayed coatings market: 5 insights

Meditech Spine achieves FDA clearance for new Cure LP indication: 5 key points

Medtronic launches 3D printing platform for titanium spinal implants: 4 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months